News Gland Pharma Limited

Equities

GLAND

INE068V01023

Market Closed - NSE India S.E. Other stock markets 07:43:54 2024-06-28 am EDT			5-day change	1st Jan Change
1,825 ^INR	+0.41%		+0.49%	-5.18%

Jun. 20	Fosun Pharma Trims Stake in Gland Pharma to 51.83%	MT
Jun. 18	Fosun Pharma Industrial Reportedly to Pare 5% Stake in Gland Pharma for $172 Million	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Fosun Pharma Trims Stake in Gland Pharma to 51.83%	Jun. 20	MT
Fosun Pharma Industrial Reportedly to Pare 5% Stake in Gland Pharma for $172 Million	Jun. 17	CI
Gland Pharma Limited Announces Management Changes	Jun. 07	CI
Gland Pharma Limited Announces Resignation of C.S. Venkatesan as Sr. Vice President (R&D) and SMP, Effective June 30, 2024 and July 1, 2024 Respectively	May. 31	CI
Gland Pharma Gets Zero Observations from US FDA for API Facility in Andhra Pradesh, India	May. 24	MT
Jefferies Adjusts Gland Pharma's Price Target to INR2,240 From INR2,400, Keeps at Buy	May. 23	MT
Gland Pharma Posts Surge in Fiscal Q4 Consolidated Net Profit	May. 23	MT
Transcript : Gland Pharma Limited, Q4 2024 Earnings Call, May 22, 2024	May. 22
Gland Pharma Limited Board Recommends Final Dividend for the Fiscal Year Ending March 31, 2024	May. 22	CI
Gland Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 22	CI
Gland Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 22	CI
Gland Pharma Gets US FDA's Approval for Generic ALS Drug	May. 07	MT
Gland Pharma Limited Receives Approval from the United States Food and Drug Administration for Edaravone Injection	May. 07	CI
Gland Pharma Gets US FDA's Approval for Generic Stem Cell Mobilizer Injection	May. 07	MT
Gland Pharma Limited Receives Approval from the United States Food and Drug Administration for Plerixafor Injection	May. 07	CI
KKR to buy India's Healthium Medtech at $839 million valuation, sources say	May. 06	RE
Gland Pharma Names COO	Apr. 29	MT
Gland Pharma Limited Approves Appointment of Mr. Satnam Singh Loomba as Chief Operating Officer, Effective May 1 ,2024	Apr. 29	CI
Gland Pharma Gets US FDA's Final Approval for Generic Drug for Luteinizing Hormone Surges	Apr. 29	MT
Gland Pharma Receives Approval for Cetrorelix Acetate for Injection	Apr. 29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Gland Pharma Limited

Equities

GLAND

INE068V01023

Summary

Filters